Forbes September 20, 2022
Susan Galer Brand Contributor SAPB RANDVOICE| Paid Program

Assume our business is always about the patient. That was how Michael Schmidt, co-founder and executive board member of Tenthpin Management Consultants, introduced a panel of clinical supply chain experts who shared their thoughts about where the industry was headed during a recent SAP life sciences event. Their conversation reflected the future of life sciences as they discussed their experiences getting closer to partners, gaining clinical supply chain efficiencies, and extracting business results from technology investments.

Speed up new medicines with deeper partner collaboration

In many ways, pharmaceutical companies are changing how they co-innovate with the contract manufacturing organizations (CMOs) that provide them with drug development and manufacturing services. David Volk, executive director of clinical supply chain at Roche, said...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Supply Chain, Technology, Trends
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Four Opportunities To Revitalize The US Biomedical Research Enterprise
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

Share This Article